Quantitative comparison of C-X-C chemokines produced by endotoxin-stimulated human alveolar macrophages
- 1 July 1998
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 275 (1) , L87-L95
- https://doi.org/10.1152/ajplung.1998.275.1.l87
Abstract
The C-X-C chemokines are a structurally related and functionally redundant family of proteins with neutrophil chemotactic activity. Many of the C-X-C chemokines are produced by endotoxin-stimulated alveolar macrophages (AMs), but knowledge of their relative quantities and their relative contributions to the total chemotactic activity released from these cells is incomplete. Human AMs were stimulated with or without Escherichia coli endotoxin for 2, 4, 8, and 24 h. The mRNA sequences of interleukin (IL)-8, the 78-amino acid epithelial cell-derived neutrophil activator (ENA-78), growth-related protein (GRO) α, GROβ, and GROγ were cloned by PCR and identified by sequence analysis. The relative mRNA quantities were compared by Northern analysis, and IL-8 was found to predominate. Similarly, IL-8 protein concentrations in the cell supernatants were consistently higher than either the ENA-78 or GRO concentration, and by 24 h, IL-8 concentrations were 10-fold higher than those of the other C-X-C chemokines. Blocking polyclonal antibodies to IL-8 substantially reduced the chemotactic activity in the AM supernatants, whereas antibodies to ENA-78 and GRO had little or no effect. We conclude that IL-8 is the predominant C-X-C chemokine and the dominant neutrophil chemoattractant accumulating in 24-h supernatants of lipopolysaccharide-stimulated human AMs. These studies provide insight into potentially effective strategies of interrupting AM-derived inflammatory signals in the lungs.Keywords
This publication has 36 references indexed in Scilit:
- The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 ReceptorJournal of Biological Chemistry, 1996
- Molecular Expression of the α-Chemokine Rabbit GRO in Escherichia coli and Characterization of Its Production by Lung Cells in Vitro and in VivoJournal of Biological Chemistry, 1996
- Antibodies against the N-terminus of IL-8 Receptor A Inhibit Neutrophil ChemotaxisBiochemical and Biophysical Research Communications, 1996
- Biological and kinetic characterization of recombinant human macrophage inflammatory peptides 2 alpha and beta and comparison with the neutrophil activating peptide 2 and interleukin 8Cytokine, 1994
- Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2Molecular Immunology, 1993
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991
- Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues.The Journal of Experimental Medicine, 1990
- Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.The Journal of Experimental Medicine, 1990
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.Journal of Clinical Investigation, 1980